I was reading a short blurb about UTHR yesterday
|Why UTHR Trades at Lower Multiples Compared to Its Peers|
I was expecting some great insight. But all I found was this:
The sale of a substantial number of United Therapeutics’ shares by insiders can be considered a guiding influence on the company’s share price and valuation multiples.
Ok. I am not crazy about insider sales. So I looked further. The CEO has sold quite a few shares. In fact, Yahoo Finance says she only has 400 shares left. That seemed to me a concern
Then, how can she just have 400 shares yet be selling over 1,000 every month? Is dark magic at play? I went to Sec.Gov and checked her form 4. It shows that while she personally only has the 400 shares, she controls a trust of over 600,000 shares!
That seems good to know. So she has over $76 million of direct interest in UTHR doing well. I had tried to find this in several spots on the internet, but had to go to the source documents. I feel better now.